ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,512.90
-0.33%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ChromaDex Corporation (CDXC)

  7. ChromaDex Corporation (CDXC) News

ChromaDex (CDXC)

ChromaDex Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CDXC
DateTimeSourceHeadlineSymbolCompany
23/05/202413:34Business WireChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024NASDAQ:CDXCChromaDex Corporation
22/05/202413:32Business WireChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year AwardNASDAQ:CDXCChromaDex Corporation
08/05/202421:04Business WireChromaDex Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:CDXCChromaDex Corporation
08/05/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXCChromaDex Corporation
08/05/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDXCChromaDex Corporation
30/04/202413:32Business WireChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy SupplementNASDAQ:CDXCChromaDex Corporation
25/04/202413:34Business WireChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®NASDAQ:CDXCChromaDex Corporation
24/04/202413:34Business WireChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024NASDAQ:CDXCChromaDex Corporation
23/04/202413:32Business WireChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers MarketNASDAQ:CDXCChromaDex Corporation
26/03/202412:32Business WireChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency ProgramNASDAQ:CDXCChromaDex Corporation
06/03/202421:04Business WireChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 ResultsNASDAQ:CDXCChromaDex Corporation
06/03/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXCChromaDex Corporation
06/03/202421:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CDXCChromaDex Corporation
24/02/202402:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXCChromaDex Corporation
24/02/202401:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXCChromaDex Corporation
21/02/202413:32Business WireChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024NASDAQ:CDXCChromaDex Corporation
05/02/202413:32Business WireChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024NASDAQ:CDXCChromaDex Corporation
26/01/202421:08Business WireChromaDex to Present at the Lytham Partners 2024 Investor Select ConferenceNASDAQ:CDXCChromaDex Corporation
20/12/202314:04Business WireChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®NASDAQ:CDXCChromaDex Corporation
13/12/202321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXCChromaDex Corporation
12/12/202315:30PR Newswire (US)Neurohacker Collective and ChromaDex Partner to Optimize Cellular Health with the Debut of Qualia NAD+NASDAQ:CDXCChromaDex Corporation
04/12/202321:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXCChromaDex Corporation
30/11/202313:34Business WireA Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson's Disease (PD)NASDAQ:CDXCChromaDex Corporation
15/11/202313:32Business WireNewly Published Phase II Clinical Study Demonstrates that Supplementation with Niagen®, Patented Nicotinamide Riboside (NR), Elevates NAD+ Up to Fourfold, Improving Motor Coordination and Eye Movement in Ataxia Telangiectasia (AT) PatientsNASDAQ:CDXCChromaDex Corporation
09/11/202313:32Business WireChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, November 14, 2023NASDAQ:CDXCChromaDex Corporation
08/11/202321:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXCChromaDex Corporation
08/11/202321:02Business WireChromaDex Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:CDXCChromaDex Corporation
08/11/202321:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDXCChromaDex Corporation
01/11/202312:34Business WireChromaDex Debuts Clinical Strength Tru Niagen® Pro 1,000mg Featuring Niagen® (Patented Nicotinamide Riboside), One of the Most Efficient Nicotinamide Adenine Dinucleotide (NAD+) Boosters Available, to Consumers NationwideNASDAQ:CDXCChromaDex Corporation
31/10/202312:34Business WireChromaDex to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023NASDAQ:CDXCChromaDex Corporation
 Showing the most relevant articles for your search:NASDAQ:CDXC

Your Recent History

LSE
ZED
Zenova
LSE
CHLL
Chill Brands
LSE
KEFI
Kefi Gold And Copper
LSE
SAR
Sareum
LSE
GKP
Gulf Keystone Petroleum
LSE
GOLD
LSE
BIRD
Blackbird
LSE
VAST
Vast Resources
LSE
POS
Plexus
LSE
LLOY
Lloyds Banking
LSE
AVCT
Avacta
LSE
KRS
Keras Resources
LSE
VOD
Vodafone
LSE
GPM
Golden Prospect Precious...
LSE
TERN
Tern
LSE
BARC
Barclays
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved